Description
A ROCK-I and II inhibitor (IC50s = 14.5 and 6.2 nM, respectively) that functions by binding to the ATP binding site of the kinase; suppresses the activation of ROCK substrates MLC-2 and the MLC phosphatase PP1 regulatory subunit MYPT1 at 100 nM in cancer cells
Formal name: N-[(3-hydroxyphenyl)methyl]-N’-[4-(4-pyridinyl)-2-thiazolyl]-urea
Synonyms:
Molecular weight: 326.4
CAS: 1342278-01-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|ROCK||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|ROCK Signaling||Research Area|Cell Biology|Cytoskeleton & Motor Proteins